These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 4369583)

  • 21. The primary hyperlipoproteinemias.
    Bybee DE; Hamilton RD
    J Ky Med Assoc; 1974 Dec; 72(12):658-62. PubMed ID: 4373515
    [No Abstract]   [Full Text] [Related]  

  • 22. Hyperlipidemia as the first biochemical manifestation of primary hepatic amyloidosis.
    Couture P; LeBlanc F; Gagnon P; Gagnon O; Gagné C
    Am J Gastroenterol; 1997 Jun; 92(6):1046-7. PubMed ID: 9177530
    [No Abstract]   [Full Text] [Related]  

  • 23. [Phenotyping of secondary hyperlipoproteinemia in diabetics].
    Naruszewicz M; Buczkowska-Szymańska A; Hintz R; Drewnowska I
    Pol Tyg Lek; 1974 Apr; 29(16):653-6. PubMed ID: 4363821
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical aspects of hyperlipoproteinemia.
    Crepaldi G; Fellin R
    Ann Biol Clin (Paris); 1974; 32(4):309-22. PubMed ID: 4376343
    [No Abstract]   [Full Text] [Related]  

  • 25. Colloids decrease clot propagation and strength: role of factor XIII-fibrin polymer and thrombin-fibrinogen interactions.
    Nielsen VG
    Acta Anaesthesiol Scand; 2005 Sep; 49(8):1163-71. PubMed ID: 16095459
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Theories of blood coagulation. Properties and interactions of blood clotting factors.
    Kazal LA
    Ann Clin Lab Sci (1971); 1971; 1(2):139-54. PubMed ID: 4949446
    [No Abstract]   [Full Text] [Related]  

  • 27. Familial hyperlipidemias. Diagnosis and treatment.
    Fleischmajer R; Dowlati Y; Reeves JR
    Arch Dermatol; 1974 Jul; 110(1):43-50. PubMed ID: 4371196
    [No Abstract]   [Full Text] [Related]  

  • 28. Fibrin crosslinking demonstrated by thrombelastography.
    Tyler HM
    Thromb Diath Haemorrh; 1969 Nov; 22(2):398-400. PubMed ID: 5380959
    [No Abstract]   [Full Text] [Related]  

  • 29. [Modification of serum lipoproteins by soy bean proteins].
    Richter WO; Weisweiler P; Schwandt P
    MMW Munch Med Wochenschr; 1981 Nov; 123(46):1755-6. PubMed ID: 6796844
    [No Abstract]   [Full Text] [Related]  

  • 30. [Fibrin stabilization and factor XIII substitution in malignant tumors (author's transl)].
    Zöller H
    Arzneimittelforschung; 1977 Jul; 27(7):1500-2. PubMed ID: 578483
    [No Abstract]   [Full Text] [Related]  

  • 31. [Theoretical and clinical aspects of fibrin stabilization in the post-operative phase].
    Schwering H; Zimmermann RE; Wittrin G; Kessler B
    Chirurg; 1981 Jan; 52(1):41-5. PubMed ID: 7471966
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acquired factor XIII inhibitor in monoclonal gammopathy of undetermined significance: characterization and cross-linked fibrin ultrastructure.
    Luo Y; Zhang G; Zuo W; Zheng W; Dai C
    Ann Hematol; 2010 Aug; 89(8):833-4. PubMed ID: 19953252
    [No Abstract]   [Full Text] [Related]  

  • 33. Alterations of haemostasis parameters with special reference to fibrin stabilization, factor XIII and fibronectin in patients with obliterative atherosclerosis.
    Kłoczko J; Wojtukiewicz M; Bielawiec M; Zuch A
    Thromb Res; 1988 Sep; 51(6):575-81. PubMed ID: 3187967
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effect of bezafibrate on disorders of lipid metabolism].
    Stryjek-Kamińska D; Ilińska-Debniak K; Bartosiewicz W; Szczepanik Z
    Pol Tyg Lek; 1983 Dec; 38(50):1567-71. PubMed ID: 6379618
    [No Abstract]   [Full Text] [Related]  

  • 35. Biochemical abnormalities associated with ocular hypertension and low tension glaucoma.
    Winder AF; Paterson G; Miller SJ
    Trans Ophthalmol Soc U K (1962); 1974 Jul; 94(2):518-24. PubMed ID: 4377696
    [No Abstract]   [Full Text] [Related]  

  • 36. [Dyslipidemia and blood coagulation].
    Serrano Júnior CV; Ramires JA
    Arq Bras Cardiol; 1995 Sep; 65(3):273-7. PubMed ID: 8579517
    [No Abstract]   [Full Text] [Related]  

  • 37. Evidence for abnormalities in clotting and thrombolysis as a risk factor for stroke.
    Pilgeram LO; Chee AN; Von dem Bussche G
    Stroke; 1973; 4(4):643-57. PubMed ID: 4723694
    [No Abstract]   [Full Text] [Related]  

  • 38. [Characteristics of lipoprotein metabolism impairments in nephrotic syndrome].
    Titov VN; Tvorogova MG; Levitova EN; Krylova EA
    Vopr Med Khim; 1983; 29(2):17-23. PubMed ID: 6858031
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection and differentiation of primary hyperlipoproteinemias.
    Plamieniak Z
    Mater Med Pol; 1974; 6(3):227-34. PubMed ID: 4374608
    [No Abstract]   [Full Text] [Related]  

  • 40. Lysis of clots prepared from whole blood and plasma.
    Taylor FB; Carroll RC; Gerrard J; Esmon CT; Radcliffe RD
    Fed Proc; 1981 May; 40(7):2092-8. PubMed ID: 7194803
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.